Eventide Asset Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-313,509
| Closed | -$2.16M | – | 159 |
|
|
2023
Q1 | $2.16M | Sell |
313,509
-81,209
| -21% | -$560K | 0.04% | 136 |
|
|
2022
Q4 | $2.92M | Sell |
394,718
-1,949
| -0.5% | -$14.4K | 0.06% | 130 |
|
|
2022
Q3 | $4.09M | Hold |
396,667
| – | – | 0.08% | 126 |
|
|
2022
Q2 | $5.17M | Buy |
396,667
+156,254
| +65% | +$2.04M | 0.11% | 118 |
|
|
2022
Q1 | $3.97M | Buy |
240,413
+8,036
| +3% | +$133K | 0.06% | 127 |
|
|
2021
Q4 | $6.75M | Hold |
232,377
| – | – | 0.09% | 122 |
|
|
2021
Q3 | $11.8M | Buy |
232,377
+66,667
| +40% | +$3.38M | 0.16% | 118 |
|
|
2021
Q2 | $19.8M | Hold |
165,710
| – | – | 0.27% | 95 |
|
|
2021
Q1 | $29.8M | Hold |
165,710
| – | – | 0.44% | 73 |
|
|
2020
Q4 | $44.3M | Buy |
165,710
+9,490
| +6% | +$2.54M | 0.68% | 52 |
|
|
2020
Q3 | $35.6M | Buy |
+156,220
| New | +$35.6M | 0.7% | 47 |
|